Puma Biotechnology, Inc. (PBYI)
6.84
+0.03
(+0.44%)
USD |
NASDAQ |
May 20, 10:15
Puma Biotechnology Total Liabilities (Quarterly) : 64.28M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 651.71M |
| AbbVie, Inc. | 143.08B |
| Agios Pharmaceuticals, Inc. | 75.88M |
| Editas Medicine, Inc. | 144.93M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 192.70M |
| Shareholders Equity (Quarterly) | 128.42M |
| Debt to Equity Ratio | 0.1242 |
| Current Ratio | 2.381 |
| Net Debt Paydown Yield | 3.58% |